Avantor Inc (AVTR)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: LABORATORY ANALYTICAL INSTRUMENTS

RADNOR CORPORATE CENTER, BUILDING ONE RADNOR, PA 19087

Avantor, Inc. manufactures and distributes chemicals, reagents, and laboratory supplies. The Company offers amino acids, silicones, bioreagents, denaturants, gas, solvents, stains, dyes, and minerals. Avantor serves biopharma, healthcare, education and government, advanced technologies, life sciences, and applied materials industries worldwide.

Data as of 2020-07-04
Market Cap10.086 Billion Shares Outstanding575.346 Million Avg 30-day Volume5.464 Million
P/E Ratio Dividend Yield EPS-0.63
Price/Sales2.218 Price cash flow ratio18.4 Price free cash flow ratio21.6
Book Value2.5 Price to Tangible Book-1.81 Alpha
Short Interest Ratio1.8 % Short Interest to Float1.8 R-squared
BETA 52-week High/Low19.5 / 6.655 Stddev
View SEC Filings from AVTR instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 2 2 (0.13%)
13F Filers holding this stock: 168 56 (3.67%)
Aggregate 13F shares on 03/31/2020: 452.72 Million 230.143 Million
Aggregate 13F shares on 12/31/2019: 460.547 Million 210.079 Million
Percent change: -1.70% 9.55%
Funds creating new positions: 45 18
Funds Adding to an existing position: 57 18
Funds closing out their position: 38 21
Funds reducing their position: 52 15
Heat Map Ranking for 03/31/2020 285
Heat Map Ranking for 12/31/2019 40
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AVTR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AVTR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

62.2 Million total shares from 8 transactions

Exercise Derivative Conversion (M)

65 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ANDRES JUAN

  • Director
0 2020-06-17 1

SACHDEV RAKESH

  • Director
723,752 2020-06-05 1

OHRI DEVASHISH EVP, IMEA

  • Officer
151,671 2020-05-29 4

GUPTA RAJIV

  • Director
6,468 2020-05-27 2

SUMME GREGORY L

  • Director
12,736 2020-05-27 2

NEW MOUNTAIN INVESTMENTS III, LLC

NEW MOUNTAIN PARTNERS III LP

NEW MOUNTAIN CAPITAL, L.L.C.

NEW MOUNTAIN CAPITAL GROUP, L.P.

NM HOLDINGS GP, L.L.C.

KLINSKY STEVEN B

  • 10% Owner
89,591,565 2020-05-26 1

WONDRASCH MICHAEL EVP & CIO

  • Officer
154,087 2020-05-22 4

BROPHY GERARD EVP, BIOPHARMA PRODUCTION

  • Officer
196,583 2020-05-20 4

SZLOSEK THOMAS A EVP & CFO

  • Officer
266,134 2020-05-17 3

VANDERHAEGEN FREDERIC EVP, EUROPE

  • Officer
237,431 2020-05-17 3

BRAMWELL JAMES EVP, STRATEGIC PARTNERS

  • Officer
127,788 2020-05-17 2

COUTURIER CHRISTOPHE EVP, SERVICES

  • Officer
162,932 2020-05-17 2

STUBBLEFIELD MICHAEL CEO

  • Officer
1,266,935 2020-05-17 3

ECK STEVEN W SVP & CHIEF ACCOUNTING OFFICER

  • Officer
23,483 2020-05-17 2

MILLER JUSTIN EVP & GENERAL COUNSEL

  • Officer
136,394 2020-05-17 2

MCALLISTER ERIC EVP, CHRO

  • Officer
197,899 2020-05-17 3

SEVERINO MICHAEL

  • Director
10,022 2020-04-23 2

PEACOCK JONATHAN M

  • Director
161,195 2020-02-21 1

FOXE TANYA EVP, OPERATIONS & SUPPLY CHAIN

  • Officer
39,458 2020-02-21 1

SHAW CHRISTI

  • Director
25,605 2020-02-21 1

HENRICHWARK SVEN EVP, APAC REGION

  • Officer
14,375 2020-01-21 2

MURRAY MARK CHRISTOPHER EVP, BIOMATERIALS & AT

  • Officer
12,376 2020-01-13 2

GOLDMAN SACHS & CO. LLC

STONEBRIDGE 2017, L.P.

STONEBRIDGE 2017 OFFSHORE, L.P.

VWR PARTNERS, L.P.

BROAD STREET PRINCIPAL INVESTMENTS, L.L.C.

BRIDGE STREET OPPORTUNITY ADVISORS, L.L.C.

GOLDMAN SACHS GROUP INC

STONEBRIDGE 2018, L.P.

STONEBRIDGE 2018 OFFSHORE, L.P.

131,487,059 2019-06-13 0

NATAURI JO

131,487,059 2019-06-13 0

CONNOLLY THOMAS

131,487,059 2019-06-13 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

OHRI DEVASHISH - Officer EVP, IMEA

2020-05-29 M 35,000 d 88,440 151,671.00 direct

OHRI DEVASHISH - Officer EVP, IMEA

2020-05-29 M 35,000 $1.60 a 186,671 151,671.00 direct

OHRI DEVASHISH - Officer EVP, IMEA

2020-05-29 M 30,000 d 185,160 151,671.00 direct

OHRI DEVASHISH - Officer EVP, IMEA

2020-05-29 S 30,000 $18.57 d 151,671 151,671.00 direct

OHRI DEVASHISH - Officer EVP, IMEA

2020-05-29 S 35,000 $19.07 d 151,671 151,671.00 direct yes

OHRI DEVASHISH - Officer EVP, IMEA

2020-05-29 M 30,000 $1.60 a 181,671 151,671.00 direct

NEW MOUNTAIN INVESTMENTS III, LLC - > 10% Owner see footnote

NEW MOUNTAIN PARTNERS III LP - > 10% Owner see footnote

NEW MOUNTAIN CAPITAL, L.L.C. - > 10% Owner see footnote

NEW MOUNTAIN CAPITAL GROUP, L.P. - > 10% Owner see footnote

NM HOLDINGS GP, L.L.C. - > 10% Owner see footnote

KLINSKY STEVEN B - > 10% Owner see footnote

2020-05-26 S 20,886,424 $15.90 d 89,591,565 89,591,565.00 indirect

GOLDMAN SACHS & CO. LLC see footnotes

STONEBRIDGE 2017, L.P. see footnotes

STONEBRIDGE 2017 OFFSHORE, L.P. see footnotes

VWR PARTNERS, L.P. see footnotes

BROAD STREET PRINCIPAL INVESTMENTS, L.L.C. see footnotes

BRIDGE STREET OPPORTUNITY ADVISORS, L.L.C. see footnotes

GOLDMAN SACHS GROUP INC see footnotes

STONEBRIDGE 2018, L.P. see footnotes

STONEBRIDGE 2018 OFFSHORE, L.P. see footnotes

2020-05-26 S 13,726,411 $15.90 d 58,881,710 131,487,059.00 indirect

CONNOLLY THOMAS see footnotes

2020-05-26 S 13,726,411 $15.90 d 58,881,710 131,487,059.00 indirect

NATAURI JO see footnotes

2020-05-26 S 13,726,411 $15.90 d 58,881,710 131,487,059.00 indirect

WONDRASCH MICHAEL - Officer EVP & CIO

2020-05-22 S 22,987 $17.82 d 154,087 154,087.00 direct

BROPHY GERARD - Officer EVP, BIOPHARMA PRODUCTION

2020-05-20 S 25,495 $17.36 d 196,583 196,583.00 direct yes

BROPHY GERARD - Officer EVP, BIOPHARMA PRODUCTION

2020-05-17 F 13,790 $17.86 d 222,078 222,078.00 direct

ECK STEVEN W - Officer SVP & CHIEF ACCOUNTING OFFICER

2020-05-17 F 573 $17.86 d 23,483 23,483.00 direct

MCALLISTER ERIC - Officer EVP, CHRO

2020-05-17 F 9,155 $17.86 d 197,899 197,899.00 direct

VANDERHAEGEN FREDERIC - Officer EVP, EUROPE

2020-05-17 F 2,210 $17.86 d 237,431 237,431.00 direct

WONDRASCH MICHAEL - Officer EVP & CIO

2020-05-17 F 9,155 $17.86 d 177,044 177,044.00 direct

BRAMWELL JAMES - Officer EVP, STRATEGIC PARTNERS

2020-05-17 F 12,102 $17.86 d 127,788 127,788.00 direct

OHRI DEVASHISH - Officer EVP, IMEA

2020-05-17 F 16,791 $17.86 d 151,671 151,671.00 direct

COUTURIER CHRISTOPHE - Officer EVP, SERVICES

2020-05-17 F 11,189 $17.86 d 162,932 162,932.00 direct

SZLOSEK THOMAS A - Officer EVP & CFO

2020-05-17 F 21,287 $17.86 d 266,134 266,134.00 direct

STUBBLEFIELD MICHAEL - Officer CEO

2020-05-17 F 108,700 $17.86 d 1,266,935 1,266,935.00 direct

MILLER JUSTIN - Officer EVP & GENERAL COUNSEL

2020-05-17 F 9,155 $17.86 d 136,394 136,394.00 direct

SUMME GREGORY L - Director

2020-05-08 A 7,582 a 7,582 7,582.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments